Marcelo V. Negrão

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial”.

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Cancer Cell(2022)10.1016/j.ccell.2022.06.006

N/A

3.9DataRank · unranked

106 citations

Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Hai T. Tran, Don L. Gibbons +22 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0.769DataRank · unranked

168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0.708DataRank · unranked

111 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.07.005

N/A

0.701DataRank · unranked

106 citations

Joao V. Alessi, Arielle Elkrief, Xinan Wang, Alessio Cortellini, Y Y Li +27 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0.494DataRank · unranked

26 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1735

N/A

0.345DataRank · unranked

9 citations

Hui Li, Alessandro Di Federico, Jia Wu, Hong Chen, Eleonora Gariazzo +26 more

An atlas of epithelial cell states and plasticity in lung adenocarcinoma

Nature(2024)10.1038/s41586-024-07113-9

N/A

0DataRank · unranked

163 citations

Ansam Sinjab, Zahraa Rahal, Anne M. Lynch, Warapen Treekitkarnmongkol, Yuejiang Liu +33 more

Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS -Mutant Non–Small Cell Lung Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0421

N/A

0DataRank · unranked

67 citations

Ximo Pechuan-Jorge, Teng Zhou, Minh Truong, Xin Hu, Frank Rojas +22 more

BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape

npj Precision Oncology(2024)10.1038/s41698-024-00552-7

N/A

0DataRank · unranked

38 citations

Rachel E. Sanborn, Marcelo V. Negrão, Aria Vaishnavi, Egbert F. Smit, David Planchard

Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2310

N/A

0DataRank · unranked

21 citations

Alvaro G. Paula, David Molkentine, Laura D. Hover, Monique B. Nilsson, Natalie I. Vokes +17 more

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.02.023

N/A

0DataRank · unranked

17 citations

Komal Shah, Mitchell Parma, Kaiwen Wang, Eric K. Singhi, Whitney E. Lewis +23 more

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

0DataRank · unranked

194 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011458

N/A

0DataRank · unranked

5 citations

Young‐Hee Lee, Nathaniel Deboever, Marcelo V. Negrão, Hai T. Tran, Edwin Parra +17 more

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Science Translational Medicine(2020)10.1126/scitranslmed.aaz4589

N/A

0DataRank · unranked

181 citations

Huiying Sun, Jacqulyne Robichaux, Matthias Pfeifer, Ultan McDermott, Jon Travers +19 more

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.010

N/A

0DataRank · unranked

126 citations

Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail +34 more

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.05.021

N/A

0DataRank · unranked

73 citations

Victoria M. Raymond, Richard B. Lanman, Jacqulyne Robichaux, Junqin He, Monique B. Nilsson +17 more

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002891

N/A

0DataRank · unranked

292 citations

Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen +33 more

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.09.021

N/A

0DataRank · unranked

137 citations

Daniel J. McGrail, Salah-Eddine Bentebibel, Cara Haymaker, Angelo Ravelli, Marie‐Andrée Forget +31 more

The histologic phenotype of lung cancers may be driven by transcriptomic features rather than genomic characteristics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.01.425056

N/A

0DataRank · unranked

0 citations

Hussein A. Abbas, Marcelo V. Negrão, Maheshwari Ramineni, Xin Hu, Junya Fujimoto +24 more

Molecular parameters impacting the success rate of a lung cancer PDX model.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20592

N/A

0DataRank · unranked

0 citations

Shawna M. Hubert, Ran Zhang, Xingzhi Song, Tatiana V. Karpinets, Annikka Weissferdt +15 more